000 | 01791 a2200541 4500 | ||
---|---|---|---|
005 | 20250515091049.0 | ||
264 | 0 | _c20080313 | |
008 | 200803s 0 0 eng d | ||
022 | _a1348-4540 | ||
024 | 7 |
_a10.1507/endocrj.k07-047 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiyata, Ichiro | |
245 | 0 | 0 |
_aSuccessful intrauterine therapy for fetal goitrous hypothyroidism during late gestation. _h[electronic resource] |
260 |
_bEndocrine journal _cDec 2007 |
||
300 |
_a813-7 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmniotic Fluid _xdrug effects |
650 | 0 | 4 |
_aAntithyroid Agents _xadverse effects |
650 | 0 | 4 |
_aCongenital Hypothyroidism _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFetal Diseases _xdrug therapy |
650 | 0 | 4 | _aFetal Therapies |
650 | 0 | 4 | _aGestational Age |
650 | 0 | 4 |
_aGoiter _xchemically induced |
650 | 0 | 4 |
_aGraves Disease _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperthyroidism _xdrug therapy |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaternal-Fetal Exchange _xdrug effects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aPregnancy Trimester, Third |
650 | 0 | 4 |
_aPropylthiouracil _xadverse effects |
650 | 0 | 4 |
_aThyroxine _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAbe-Gotyo, Noriko | |
700 | 1 | _aTajima, Asako | |
700 | 1 | _aYoshikawa, Hideki | |
700 | 1 | _aTeramoto, Satoshi | |
700 | 1 | _aSeo, Masami | |
700 | 1 | _aKanno, Kei-Ichi | |
700 | 1 | _aSugiura, Kentaro | |
700 | 1 | _aTanaka, Tadao | |
700 | 1 | _aEto, Yoshikatsu | |
773 | 0 |
_tEndocrine journal _gvol. 54 _gno. 5 _gp. 813-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1507/endocrj.k07-047 _zAvailable from publisher's website |
999 |
_c17438744 _d17438744 |